
|Articles|April 15, 2019
Private equity and ophthalmology: Will I be left behind?
If you find yourself waffling back and forth on private equity, Ruth D. Williams, MD, has some guidance tips to make the decision easier.
Advertisement
Ruth D. Williams, MD, shares the take-home message from her presentation, "Private Equity and Ophthalmology: Will I Be Left Behind?" at the 23rd annual Glaucoma 360 meeting at the Palace Hotel in San Francisco on Feb. 2, 2019.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
EURETINA 2026: Uveitis or retinitis pigmentosa? Ester Carreño, MD, PhD, on mimics
2
EURETINA 2026: Retinal signs as diagnostic clues to systemic metabolic disease
3
EURETINA 2026: Gene therapy sessions to watch in Vienna
4
What retinal imaging reveals about the brain-eye connection with Sharon Fekrat, MD, FACS, FASRS
5
















